Infliximab therapy for Netherton syndrome: A case report

Netherton syndrome (NS), also known as Comèl-Netherton syndrome, was clinically described in 1964 by Wilkinson et al1 and is characterized by the triad of ichthyosis linearis circumflexa, trichorrhexis invaginata, and atopic diathesis.1 The single entities, ichthyosis linearis circumflexa and the "bamboo hair" were previously described by Comèl2 in 1949 and Netherton3 in 1958, respectively.